
1. bmj clin evid. 2016 jan 22;2016. pii: 2402.

sickle cell disease.

meremikwu mm(1), okomo u.

author information: 
(1)department paediatrics, college medical sciences, university calabar,
calabar, nigeria.

introduction: sickle cell disease causes chronic haemolytic anaemia, dactylitis, 
and painful acute crises. also increases risk stroke, organ damage,
bacterial infections, complications blood transfusion. sub-saharan
africa, one third adults carriers defective sickle cell gene,
and 1% 2% babies born disease.
methods outcomes: conducted systematic overview, aiming answer the
following clinical question: effects pharmaceutical interventions
to prevent sickle cell crisis acute complications people sickle
cell disease? searched: medline, embase, cochrane library, other
important databases january 2015 (clinical evidence overviews updated
periodically; please check website up-to-date version this
overview).
results: update, searching electronic databases retrieved 369 studies.
after deduplication removal conference abstracts, 136 records were
screened inclusion overview. appraisal titles abstracts led 
the exclusion 99 studies review 37 full publications. of
the 37 full articles evaluated, three already included systematic reviews were
updated, two systematic reviews, two rcts, one subsequent rct added at
this update. performed grade evaluation 12 pico combinations.
conclusions: systematic overview, categorised efficacy five
interventions based information effectiveness safety of
antibiotic prophylaxis children aged 5 years, antibiotic prophylaxis 
children aged 5 years older, hydroxyurea, malaria chemoprophylaxis, and
pneumococcal vaccines.


pmcid: pmc4725622
pmid: 26808098  [indexed medline]

